About Curadev Pharma
Curadev Pharma is a company based in Noida (India) founded in 2010 by Arjun Surya and Manish Tandon. Curadev Pharma has raised $881.1 thousand across 2 funding rounds from investors including Department of Biotechnology, Vasantha Surya and Arjun Surya. The company has 46 employees as of April 03, 2024. Curadev Pharma offers products and services including STING Agonist CRD3874-SI, Vaccine Adjuvants, and Acetate Metabolism Modulators. Curadev Pharma operates in a competitive market with competitors including Syndax, Annexon, Auron Therapeutics, Clovis Oncology and C4X Discovery, among others.
- Headquarter Noida, India
- Employees 46 as on 03 Apr, 2024
- Founders Arjun Surya, Manish Tandon
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curadev Pharma Private Limited
- Date of Incorporation 07 Jan, 2010
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$1.67 M (USD)-60.66as on Mar 31, 2023
-
Net Profit
-$4.35 M (USD)-186.97as on Mar 31, 2023
-
EBITDA
-$5.03 M (USD)-50.33as on Mar 31, 2023
-
Total Equity Funding
$881.1 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Department of Biotechnology
& 3 more
-
Employee Count
46
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curadev Pharma
Curadev Pharma offers a comprehensive portfolio of products and services, including STING Agonist CRD3874-SI, Vaccine Adjuvants, and Acetate Metabolism Modulators.
Therapeutic for advanced cancer treatment in clinical trials
Compounds enhancing immune response in vaccines
Agents targeting metabolic pathways for disease treatment
Funding Insights of Curadev Pharma
Curadev Pharma has successfully raised a total of $881.1K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Curadev Pharma
Curadev Pharma has secured backing from 4 investors, including institutional and angel investors. Prominent investors backing the company include Department of Biotechnology, Vasantha Surya and Arjun Surya.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked | |
|
VS
Vasantha Surya |
-
|
Locked | Locked | Locked |
|
AS
Arjun Surya |
-
|
Locked | Locked | Locked |
Investor details for Curadev Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curadev Pharma
Investment portfolio details for Curadev Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curadev Pharma
Detailed financials for Curadev Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curadev Pharma Comparisons
Peer comparison for Curadev Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curadev Pharma
Curadev Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syndax, Annexon, Auron Therapeutics, Clovis Oncology and C4X Discovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Developer of cancer therapeutics for the treatment of blood cancer
|
|
| Locked | Locked | Locked |
Develops innovative immunotherapy drugs for cancer treatment.
|
|
| Locked | Locked | Locked |
Developer of optimized drug discovery and design services
|
|
| Locked | Locked | Locked |
Anti-cancer immunotherapies are developed targeting tumor micro-environment.
|
Detailed competitors of Curadev Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curadev Pharma
Complete news archive for Curadev Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curadev Pharma
Curadev Pharma was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Curadev Pharma is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Curadev Pharma is a funded company, having raised a total of $881.1K across 2 funding rounds to date.
As of Apr 03, 2024, the latest employee count at Curadev Pharma is 46.
Annual revenue of Curadev Pharma is $1.67M as on Mar 31, 2023.
Curadev Pharma was founded in 2010 in Noida, India, as a drug discovery company focused on immunotherapy. RD services are provided to clients alongside internal programs targeting cancer and inflammation. Patents for dual IDOTDO inhibitors, which address immune suppression by tumors, were licensed to Roche. Coverage includes solid and liquid tumors, breast cancer, and inflammatory conditions, with an investigational new drug application filed.
Curadev Pharma's top competitors include Syndax, iTeos Therapeutics and Annexon.
Curadev Pharma offers STING Agonist CRD3874-SI, Vaccine Adjuvants, and Acetate Metabolism Modulators.
Curadev Pharma has 4 investors. Key investors include Department of Biotechnology, Vasantha Surya, Arjun Surya, and Vasantha Surya.
The valuation of Curadev Pharma is $8.77M as of Mar 2011.